Your session is about to expire
← Back to Search
Procedure
The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach
Phase 1
Waitlist Available
Led By Jesse D Pasternak, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new type of thyroid surgery done through the mouth instead of making a cut in the neck. It targets adults who need thyroid or parathyroid surgery. The goal is to see if this method is safe and practical. This new approach has been developed to avoid visible scars and improve patient satisfaction.
Eligible Conditions
- Thyroid Disease
- Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Length of stay
Neck incision
Post-operative recurrent laryngeal nerve palsy
+8 moreSecondary study objectives
Quality of Life Score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TOETVAExperimental Treatment1 Intervention
Transoral Endoscopic Thyroidectomy Vestibular Approach
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TOETVA
2019
N/A
~20
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,527 Previous Clinical Trials
503,531 Total Patients Enrolled
Jesse D Pasternak, MDPrincipal InvestigatorUniversity Health Network, Toronto